Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities
Condition(s):Myelodysplastic Syndromes; Leukemia, Myeloid, AcuteLast Updated:April 24, 2013Completed